Literature DB >> 3663467

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

G Kenter1, J M Bonfrer, A P Heintz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3663467      PMCID： PMC2002153          DOI： 10.1038/bjc.1987.176

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Diagnosis and treatment of microinvasive carcinoma of the cervix uteri.

Authors:  E Burghardt; E Holzer
Journal:  Obstet Gynecol       Date:  1977-06       Impact factor: 7.661

2.  The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges.

Authors:  J R Van Nagell; J W Roddick; D M Lowin
Journal:  Am J Obstet Gynecol       Date:  1971-08-01       Impact factor: 8.661

3.  Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.

Authors:  T Maruo; K Shibata; A Kimura; M Hoshina; M Mochizuki
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

4.  The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA.

Authors:  O P Bleker; B W Ketting; B van Wayjen-Eecen; G J Kloosterman
Journal:  Gynecol Oncol       Date:  1983-08       Impact factor: 5.482

5.  Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.

Authors:  G Ueda; Y Inoue; M Yamasaki; M Inoue; Y Tanaka; K Hiramatsu; J Saito; T Nishino; Y Abe
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

6.  Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.

Authors:  H Kato; H Morioka; S Aramaki; K Tamai; T Torigoe
Journal:  Am J Obstet Gynecol       Date:  1983-02-01       Impact factor: 8.661

7.  Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens.

Authors:  Y Suehiro; H Kato; M Nagai; T Torigoe
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

8.  Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.

Authors:  H Kato; T Torigoe
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

9.  Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.

Authors:  H Kato; H Morioka; H Tsutsui; S Aramaki; T Torigoe
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

10.  Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.

Authors:  H Kato; K Tamai; H Morioka; M Nagai; T Nagaya; T Torigoe
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860
  10 in total
  1 in total

1.  Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma.

Authors:  S Goldman; C Svensson; M Brönnergård; B Glimelius; G Wallin
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.